Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00964821 · ClinicalTrials.gov registry record
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
A clinical trial of Lymphoma and Leukemia, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 459
- Enrollment target
- 2
- Study locations
NCT00964821: Completed study of Lymphoma and Leukemia, sponsored by City of Hope Medical Center.
NCT00964821 is a study of Lymphoma and Leukemia that has completed, run by City of Hope Medical Center. The registered enrollment target is 459 participants, roughly in line with the 482-participant average among 299 other Lymphoma trials with a reported enrollment target. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00964821, a study of Lymphoma and Leukemia, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 459 participants
- Enrollment target
- 2
- Study locations
Study Summary
RATIONALE: Studying immune response to flu vaccine in patients who have undergone a stem cell transplant may help doctors plan the best treatment. PURPOSE: This clinical trial is studying flu vaccine to see how well it works in preventing infection in patients who have undergone a stem cell transplant and in healthy volunteers.
Conditions Studied
Interventions
- BIOLOGICAL trivalent influenza vaccine
- OTHER Laboratory biomarker analysis
- OTHER Immunoenzyme technique
Study Locations (2)
California
- City of Hope Comprehensive Cancer Center - Duarte
- City of Hope Medical Group - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 459 participants |
| Start Date | 2007-01 |
| Est. Completion | 2013-05 |
What the finished NCT00964821 record still lists
NCT00964821 is an observational study that tracks outcomes without assigning an intervention. The registered 459 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 482-participant average among 299 other Lymphoma trials with a reported enrollment target.
The record links to 7 conditions, with Lymphoma appearing as the primary indexed condition, and to 3 interventions - of which trivalent influenza vaccine is the first listed.
NCT00964821 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00964821 about?
NCT00964821 is a clinical study titled "Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant". RATIONALE: Studying immune response to flu vaccine in patients who have undergone a stem cell transplant may help doctors plan the best treatment. PURPOSE: This clinical trial is studying flu vaccine to see how well it works in preventing infection in patients who have undergone a stem cell transpl...
What is the current status of trial NCT00964821?
This trial is currently completed. The enrollment target is 459 participants. The study started on 2007-01. Estimated completion is 2013-05.
What conditions does trial NCT00964821 study?
This clinical trial studies the following conditions: Lymphoma, Leukemia, Myelodysplastic Syndromes, Multiple Myeloma and Plasma Cell Neoplasm, Chronic Myeloproliferative Disorders.
What interventions are being tested in trial NCT00964821?
The interventions under investigation include: trivalent influenza vaccine (BIOLOGICAL), Laboratory biomarker analysis (OTHER), Immunoenzyme technique (OTHER).
Who is sponsoring clinical trial NCT00964821?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00964821 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00964821's enrollment target sits among peer trials
459 21st of 299 higher than 279 of 299 other Lymphoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
RECRUITING · Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04452825 · 459 participants · NA
A New Psychotherapy Intervention for Older Cancer Patients
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia